Familial Dysautonomia Completed Phase 2 Trials for Carbidopa (DB00190)

Also known as: Riley-Day syndrome / Dysautonomia, Familial / Familial dysautonomia [Riley-Day] / HSAN III

IndicationStatusPhase
DBCOND0048634 (Familial Dysautonomia)Completed2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02553265Carbidopa for the Treatment of Excessive Blood Pressure VariabilityTreatment